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Protein-thiol groups that react with dihydroxydinaphthyl disulphide during a 7 h incubation (so-called reac- 
tive protein thiols, PSH,) have been quantitatively measured on sections of human uterine cervix by micro- 
cytospectrophotometry. Measurements were made on areas (1 pmz) of epithelium and adjoining stroma in 
samples of normal cervix, and in samples obtained from patients with dysplasia, carcinoma-in-situ and inva- 
sive cancer. The ratio of PSH, in epithelium to stroma is substantially reduced in the pathological conditions 
compared with normal and in apparently normal adjacent areas. Such changes in PSH, are discussed in 
relation to the redox balance of the tissue, and free radical disturbances previously described. 
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1. INTRODUCTION 
Free radical disturbances are known to occur in 
many clinically important diseases, and in a variety 
of chemically induced tissue injuries [l-4]. Exten- 
sive and detailed studies on some experimental 
models of tissue damage have demonstrated clearly 
that the associated free radical disturbances can be 
of primary importance in the initiation of the gross 
metabolic and cellular perturbations that occur 
[5,6]. However, in many other situations where 
free radical disturbances have been proposed to 
contribute to pathological events, the evidence for 
the occurrence of reactive free radical in- 
termediates and for their participation in the 
primary stages of tissue injury and disease is in- 
direct, mainly as a consequence of the tissue con- 
centrations of the presumed free radical in- 
termediates being too low and too transient for 
direct detection by the definitive process of ESR 
spectroscopy [7]. The latter restriction does not 
apply to one type of human cancer that we have 
studied [S], carcinoma of the uterine cervix, where 
the difference in free radical content between nor- 
mal healthy tissue and tumour material is substan- 
tial and readily detectable by ESR. A very strong 
ESR signal is detectable in normal samples of 
human cervix, whereas the signal is much reduced 
or absent in samples of the tumour [8]. 
The free radical species that is present in frozen 
powders of normal human cervix has features 
characteristic of a peroxy radical 19,101. This type 
of free radical has oxidizing properties, and would 
have disturbing effects on the reduction-oxidation 
(redox) balance, including the ratio of thiol: 
disulphide groups (SH : S-S), especially around its 
locus of formation. Obviously, however, many 
other (and generally quantitatively more impor- 
tant) factors will also influence the thiol:disul- 
phide balance in cells in situ. 
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Because of the large differences in free radical 
content that occur between samples of normal and 
cancer tissue taken from human cervix, and the 
possibility that this difference will be associated 
with detectable perturbations of redox balance, we 
decided to investigate one aspect of the latter com- 
plex function of cellular metabolism using a quan- 
titative microchemical method for protein-bound 
thiol groups. A review of this microspec- 
trophotometric approach to these and related 
studies was recently presented to a symposium on 
cancer of the uterine cervix [l 11. 
Previous studies have demonstrated relation- 
ships between the rates of cell division and the thiol 
contents of normal [12] and tumour cells [13,14]. 
However, those studies concentrated on the solu- 
ble thiol-containing substances of the cell, such as 
glutathione (GSH) and protein-thiols of the 
cytosol. Only a small amount of information is 
available from studies on cellular material on the 
variations in the content of thiol-groups that are 
not easily extractable with aqueous buffer or 
aqueous alcohol (e.g. protein-thiols firmly 
associated with biomembranes), although such 
thiol groups are probably of considerable impor- 
tance in membrane function. A quantitative 
cytochemical method has been developed [15] to 
measure protein-thiol groups in fixed cells stained 
with 2,2-dihydroxy-6,6-dinaphthyl disulphide 
(DDD), and we have applied this procedure to our 
studies on sections of human uterine cervix. 
Here we give results for the measurement of 
reactive protein-thiol groups (PSH,) in epithelium 
and stroma of fixed sections of human uterine cer- 
vix, and demonstrate that the ratio of PSH, in 
epithelium to that in stroma is considerably chang- 
ed in sections prepared from samples taken from 
patients with dysplasia, carcinoma-in-situ or in- 
vasive carcinoma of the cervix compared with the 
normal situation. Moreover, measurements of 
PSH,-values in apparently normal tissue adjacent 
to an area characteristic of the pathological distur- 
bances just mentioned show trends similar to the 
changes observed in the lesions: these results are 
indicative of a diffuse change in redox balance that 
extends beyond the boundary of the lesion as 
defined by conventional histological evaluation. 
We believe these data are of considerable 
biochemical interest and may have potential 
clinical applications to pathological esions of the 
268 
uterine cervix, including carcinoma that, in some 
countries of the world, is a major cause of death 
by cancer in women [16]. 
2. MATERIALS AND METHODS 
Human tissue samples were taken during opera- 
tions for cone biopsy or hysterectomy. Normal 
samples of cervix were obtained mostly from pa- 
tients undergoing hysterectomy for fibroleio- 
myoma of the uterine body with no evidence of 
significant pathological disturbances of the uterine 
cervix; none of the patients involved in this study 
had received medication additional to that re- 
quired for surgery for one week prior to operation. 
None of the women involved in this report had 
been taking oral contraceptives in the period 
leading up to the operation. 
Serial frozen sections of 10pm thickness were 
prepared, using a TEK-11 cryostat, within 1 h of 
obtaining the samples at operation. The sections 
were fixed in methanol, and stained for reactive 
protein-thiol groups (PSH,), by the methods of 
Nohammer [ 15,171. Alternate serial sections were 
stained with haematoxylin-eosin and evaluated 
histologically. 
The extinctions of areas (1 mm2) of epithelium 
and stroma of sections stained for reactive protein- 
thiol groups were measured using a Zeiss UMSP-1 
microspectrophotometer with associated ata pro- 
cessing and a rapid scanning table attachment. Full 
details of the procedures used, and of the 
microspectrophotometer sampling analysis can be 
found in reference [ 181. Fast Blue B was obtained 
from Merck (Darmstadt); DDD was obtained from 
Sigma (Munchen). 
3. RESULTS AND DISCUSSION 
Table 1 shows data for reactive protein thiol 
groups in the epithelium and stroma of sections 
prepared from samples obtained from normal pa- 
tients, patients with dysplasia, carcinoma-in-situ 
or invasive carcinoma. It can be seen that reactive- 
PSH groups are concentrated more in epithelium 
than in stroma; the ratio of reactive protein thiol 
groups in epithelium to stroma is significantly 
higher in sections prepared from normal patients 
compared to those prepared from patients with the 
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Table 1 
Mean extinction values per unit area (E/pm’) of sections prepared from samples of 
normal dysplastic and neoplastic human uterine cervix stained for reactive protein 
thiols 
Group N Reactive protein thiols 
Epithelium Stroma 
Epithelium 
Stroma 
1. Normal 53 0.34 * 0.02 0.13 * 0.01 2.73 + 0.10 
2. Dysplasia 
a. ‘Normal tissue’ 25 0.25 f 0.03b 0.14 f 0.02”” 1.81 f 0.10” 
b. Dysplasia 33 0.27 + 0.03”” 0.18 f 0.02’ 1.61 + 0.09e 
3. Carcinoma-in-situ 
a. ‘Normal tissue’ 28 0.24 + 0.04’ 0.11 + 0.01”” 2.10 f 0.10’ 
b. Carcinoma-in-situ 29 0.25 + 0.03’ 0.16 + 0.02= 1.51 f 0.06’ 
4. Invasive cancer 
a. ‘Normal tissue’ 14 0.25 f 0.04”” 0.11 f 0.01”s 2.22 f 0.20a 
b. Invasive cancer 29 0.22 * O.OIC 0.15 f o.olns 1.55 f 0.08e 
Groups 2a, 3a and 4a give data obtained from apparently normal parts of the sections 
adjacent to the relevant lesions 2b, 3b and 4b. Mean values are given + SE. 
Probabilities (P), obtained by Student’s t-test, for the difference between the mean 
values in groups 2-4 vs the corresponding control value are shown as superscripts: 
a P < 0.05; b P < 0.02; ’ P < 0.01; d P < 0.05; e P < 0.001; ns not significant; N = 
number of individual cases 
pathological disturbances studied. 
The age range of patients in the normal groups 
was 29-81 years, with an average of 49 years. 
There was no discernible variation with age in the 
epithelium :stroma ratio in normal patients. 
The number of samples of dysplasia studied is 
too small to enable detailed statistical analysis to 
be done concerning possible differences in the 
epithelium: stroma ratio in relation to grades of 
dysplasia; however, the data so far available sug- 
gest that such variations, if they occur at all, will 
be small in comparison to the differences between 
the normal and dysplasia groups (the corre- 
sponding mean values f: SE are 2.73 k 0.10 vs 1.61 
+ 0.09; table 1). Although no significant varia- 
tions in the epithelium: stroma ratio have been 
detected between the various grades of dysplasia, 
there are progressive increases in the amounts of 
reactive protein thiols in both epithelium and 
stroma in the sequence: mild, moderate and severe 
dysplasia [ 191. 
The ratio of reactive protein thiols in epithelium 
to stroma is decreased in lesion areas classified as 
dysplasia, carcinoma-in-situ or invasive cancer 
compared to normal (table 1). With dysplasia, the 
change in the ratio results largely from an increase 
in the reactive-protein thiol content of stroma with 
a small but not statistically significant decrease in 
the epithelium; with invasive cancer and 
carcinoma-in-situ the changes in the ratio are due 
both to a decreased reactive SH in the epithelium 
and a statistically significant increase in the 
stroma. 
These differences in reactive protein-thiol 
groups of epithelium and stroma in lesions com- 
pared with normal tissue are consistent with a cur- 
rent concept that dysplasias and carcinoma-in-situ 
are different stages of the same disease-continuum 
(review [20]). However, it is clear from the results 
given in table 1 that there is no gradation of change 
in the ratio of the values found for reactive protein 
thiols in epithelium:stroma in moving from nor- 
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ma1 through dysplasias, carcinoma-in-situ to in- 
vasive cancer. 
An important feature of the results found is that 
apparently normal epithelium and stroma (as 
evaluated by conventional histological criteria) 
show changes in the ratio of reactive-proton thiol 
groups in the epithelium:stroma that reflect at 
least in part those changes found in neighbouring 
regions of dysplasia, carcinoma-in-situ or invasive 
cancer. Indeed, in one instance a pathological le- 
sion was well within the cervical canal whereas 
changes in reactive PSH, groups in epithelium and 
stroma were easily observable in apparently nor- 
mal regions around the external OS. One possible 
interpretation for such a tendency is that the 
pathological lesions studied may exert a 
widespread effect on the reactive protein thiol con- 
tent of neighbouring cells - such a field effect 
would have important biological implications and 
is under further investigation. However, we note 
that the changes found for reactive protein-thiol 
groups in areas of apparently normal tissue are not 
so marked as those found in the lesions and that 
also, the values obtained for areas of apparently 
normal tissue show rather greater variations be- 
tween individual sections than observed for the 
corresponding lesion areas. Indications of a field 
effect in samples of human cervix obtained from 
patients with carcinoma-in-situ or invasive car- 
cinoma have been reported by Millett et al. [21] 
who measured DNA content, and by Benedetto et 
al. [S] who studied the free radical content of cer- 
vix samples using ESR spectroscopy. 
An alternative possibility to consider in 
evaluating the data presented here for apparently 
normal tissue surrounding an established lesion is 
that a rather generalised (i.e. diffuse) change has 
occurred in the area containing the morphological- 
ly identifiable lesion and pre-dating the lesion 
itself. Such a type of diffuse change has been refer- 
red to by Jensen et al. [22] in relation to 
angiogenesis induced by human breast tissue, who 
have suggested preneoplastic transformation is dif- 
fuse in samples obtained from patients with mam- 
mary cancer. Recent studies on virus infections of 
the cervix in relation to cancer of that tissue 
[23-251 may also be of relevance to the results 
described here: studies of the effects of herpes and 
papilloma virus infection on the reactive protein 
thiol content of human cervix are in progress. 
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